Fig. 2From: Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancerIdentification of potential tumor antigens in BRCA. a Chromosomal distribution of differentially expressed genes in BRCA. Sample counts in mutation count (number of mutational events per case) groups (b) and genome fraction altered (% of copy number altered chromosome regions out of measured regions per case) groups (c). Genes with the top 10 highest frequencies in mutation count groups (d) and in altered genome fraction groups (e). The colors of the bar represent the group terms and the heights of the bar represent the frequency of each groupBack to article page